Immunoglobulin A nephropathy (IgAN) remains one of the most common primary glomerular diseases worldwide, yet effective treatments are limited. A new study, recently published in Frontiers, offers fresh evidence that Shenqi Dihuang decoction (SQD)—a traditional Chinese herbal formula—may exert therapeutic effects through a network of molecular and cellular mechanisms relevant to IgAN progression.
Study Overview
Researchers combined network pharmacology, machine learning, molecular docking, and single-cell transcriptomics to map how SQD components interact with disease‑related genes and pathways. They integrated SQD target predictions with gene expression signatures from IgAN patients to pinpoint overlapping disease‑modifying factors. These computational findings were then reinforced with in vitro experiments designed to mimic renal injury.
Key Molecular Targets Identified
Three genes emerged as central to SQD’s therapeutic activity:
- FOS
- MCL1
- CCND1 (Cyclin D1)
According to the analysis, these genes not only distinguished IgAN patients from healthy individuals but also clustered within biological pathways tied to amino acid and dicarboxylic acid metabolism, both of which are known to influence renal inflammation and cellular stress responses.
Immune and Regulatory Network Findings
The study also uncovered notable shifts in immune cell infiltration patterns, suggesting immunomodulation may be a relevant therapeutic effect of SQD. Researchers constructed extensive regulatory maps involving:
- 72 microRNAs
- 144 transcription factors
These networks help explain how SQD could influence inflammatory signaling and renal cell survival at multiple regulatory layers.
Active Compounds and Molecular Interactions
Molecular docking simulations highlighted strong binding affinities between the key target genes and specific SQD compounds, including:
- Cryptotanshinone
- Tanshinone IIA
- Luteolin
Such interactions support the hypothesis that these herbal constituents may drive SQD’s observed biological activity.
Single-Cell Insights Into Renal Cell Populations
By analyzing single-cell RNA sequencing datasets, investigators identified proximal tubular cells and intercalated cells as major contributors to IgAN pathology. Importantly, FOS expression increased during differentiation of these cell types, suggesting a potential link between SQD’s gene‑level effects and the behavior of specific kidney cell populations.
Laboratory Validation
In vitro experiments further confirmed that SQD protects renal cells from injury, lending biological credibility to the computational and bioinformatic predictions.
Takeaway
This multi‑layered analysis proposes FOS, MCL1, and CCND1 as key mediators through which Shenqi Dihuang decoction may influence the course of IgA nephropathy. By integrating modern data‑driven methods with traditional herbal pharmacology, the study provides a foundation for developing new targeted therapies and deepens scientific understanding of how SQD may help mitigate kidney damage in IgAN.
